Sysmex Corporation

Sysmex Corporation, proudly headquartered in Kobe, Japan, is a colossal global powerhouse and the undisputed market leader in the field of hematology and specialized in vitro diagnostics (IVD). Sysmex strictly specializes in designing, engineering, and manufacturing highly sophisticated automated clinical laboratory equipment, proprietary reagents, and advanced laboratory informatics software systems.

The company commands the dominant global market share in hematology analyzers—the critical instruments that perform complete blood counts (CBCs) and analyze blood cells with extreme, microscopic precision. Their flagship XN-Series analyzers are the absolute gold standard, functioning as the primary workhorses in massive hospital and reference laboratories worldwide. Sysmex is globally highly regarded for its exceptional Japanese engineering quality, unparalleled instrument reliability, and the sheer technological sophistication of its flow cytometry-based diagnostic methods.

Beyond its unquestioned dominance in hematology, Sysmex is rapidly and aggressively expanding its footprint in hemostasis (blood coagulation), urinalysis, immunochemistry, and advanced life sciences. A major area of their recent, heavy R&D investment focuses on revolutionary liquid biopsy technologies and advanced oncology diagnostics, seeking to detect microscopic cancer biomarkers from simple, non-invasive blood draws.

With a profound commitment to shaping the advancement of healthcare, Sysmex continuously invests in R&D, striving to provide high-value, highly sensitive testing that enables personalized medicine and improves patient outcomes globally.